INVESTMENT PORTFOLIO & PERFORMANCE

EASI / HUNGRYPANDA

EASI is a fast-growing global food-delivery ecosystem operating across Australia and 15 countries, serving diverse migrants and urban professionals. With deep local partnerships, exclusive restaurant networks, and strong unit economics in niche cultural cuisines, it captures underserved demand major platforms overlook. Its scalable cross-border model positions it as the world leader in multicultural food delivery.

EASI leads Australia’s Asian food delivery market with strong community penetration, efficient logistics, and diversified services. Its scalable model and sustainable growth make it a high-quality investment in the on-demand services sector.

IN1BANK

We backed a pioneering digital bank focused on multicultural Australia. Within two years, it delivered triple-digit user growth, expanded to 20+ cities, and achieved profitability. The fund achieved a 5× return at exit — underscoring our ability to spot and scale niche fintech winners in under-served communities.

XIAOMI

Xiaomi is a global technology leader with a strong smart-device and IoT ecosystem. Its innovation capability, efficient supply chain, and rapid global expansion position it as a benchmark investment in consumer technology.

Our early investment in OmiPay became a standout fintech success. From its early years, OmiPay scaled rapidly across Australia by delivering multicurrency payments, QR transactions, and cross-border settlement to merchants and migrants. Its strong adoption, nationwide merchant network, and rising valuation validated our conviction in backing multicultural payment infrastructure at the right moment.

OMIPAY

EWE

EWE is a leading cross-border e-commerce logistics provider linking Asia and Australia. Its robust fulfilment network, technology integration, and reliable service quality support sustained expansion, making it a strong investment in cross-border commerce infrastructure.

Our early investment in EIZ Technology became a standout SaaS and logistics success. EIZ scaled rapidly by delivering integrated warehouse, fulfilment, and multi-channel order management for Australia’s fast-growing e-commerce sector. Its hybrid SaaS-plus-3PL model drove strong recurring revenue and operational adoption, resulting in significant valuation uplift and validating our strategy of backing scalable digital infrastructure.

EIZ TECHNOLOGY

HEYTEA

HeyTea leads China’s premium tea-beverage market with strong product innovation and experiential retail. Its brand strength, digital operations, and disciplined expansion support sustained growth, making it a standout investment in the new-generation consumer sector.

MINISO has built a global lifestyle retail brand through efficient supply chains, design-driven products, and scalable expansion. Its strong international presence and resilient performance make it a successful investment in modern value retail.

MINISO

YEEYI

Yeeyi.com is a leading digital community for Australia’s Chinese population, combining content, classifieds, and local services. Its deep engagement and scalable ecosystem highlight its value as a strong digital-platform investment.

E Best delivers strong growth in digital commerce through supply-chain integration, operational efficiency, and technology-driven optimisation. Its scalable model and consistent performance demonstrate attractive investment value in consumer-tech.

E BEST

PIKMO

Our early investment in Pikmo started from zero and became a remarkable two-year success story. From inception to a current valuation of $50 million, Pikmo scaled rapidly by uniting merchants, loyalty, and card-linked offers into one powerful ecosystem. Its growth boosted SME revenues, strengthened customer retention, and generated recurring fintech value—delivering exceptional returns and validating our early vision.

Current participating in the investment in the AI health sector. Backing the company early, we supported its mission to transform maternal care through AI-driven monitoring and predictive diagnostics. As Baymatob advanced clinical trials, secured regulatory recognition, and expanded global partnerships, its valuation and impact grew rapidly—delivering strong returns while improving outcomes for mothers and babies worldwide.

BAYMATOB